SCHEMBL1831086

SCHEMBL1831086

C[N+]1=CN(c2ccccc2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CHRNA3 P32297 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ RAB9A P51151 3/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ SIGMAR1 Q99720 3/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ APOBEC3A P31941 3/20 0.34
▸ APOBEC3G Q9HC16 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ POLB P06746 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6847758 0.82 ALDH1A1 (0.51) HSD17B10ALOX15RAB9AMEN1KMT2A
SCHEMBL22189038 0.73 NPC1 (0.33) CHRNA7CYP3A4HSD17B10ALOX15CHRNB2
SCHEMBL4585103 0.73 MGLL (0.35) ADRB1
Hydrochloric Acid SCHEMBL14334302 0.72 MAPT (0.33) CYP3A4MAPK1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL1697483 0.69 MAPT (0.34) RAB9ANPC1MAPTSMN1; SMN2MAOB
SCHEMBL1836416 0.67 LMNA (0.46) CYP3A4MEN1KMT2ASIGMAR1POLB
SCHEMBL22188949 0.65 ALDH1A1 (0.34) MAPTPOLBSMN1; SMN2HTTALDH1A1
SCHEMBL1835244 0.65 SIGMAR1 (0.42) CHRNA7CYP3A4HSD17B10ALOX15CHRNB2
SCHEMBL1007069 0.59 MAPT (0.39) CHRNA7CYP3A4HSD17B10ALOX15CHRNB2
SCHEMBL576454 0.58 LMNA (0.67) CHRNA7CYP3A4HSD17B10ALOX15CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7460357-B2 Electrolyte for electrolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2008-12-02 — — US claimed
US-7072173-B2 Electrolyte for electrolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-07-04 — — US claimed
US-20060092597-A1 Electrolyte for electrolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-05-04 — — US claimed
US-20040095708-A1 Electrolyte for electolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2004-05-20 — — US claimed
EP-1394824-A1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR USING IT Mitsubishi Chemical Corporation (JP) 2004-03-03 — — EP claimed
US-9919997-B2 One-pot water-free ionic liquids synthesis using trialkyl orthoesters PUSAN NATIONAL UNIVERSITY INDUSTRY UNIVERSITY COOPERATION FOUNDATION OF PUSAN (KR) 2018-03-20 — — US disclosed
US-20160326095-A1 ONE-POT WATER-FREE IONIC LIQUIDS SYNTHESIS USING TRIALKYL ORTHOESTERS PUSAN NATIONAL UNIVERSITY INDUSTRY UNIVERSITY COOPERATION FOUNDATION OF PUSAN (KR) 2016-11-10 — — US disclosed
US-7998360-B2 Electrolysis solution for electrolytic capacitor, and electrolytic capacitor MITSUBISHI CHEMICAL CORPORATION (JP) 2011-08-16 — — US disclosed
EP-2323144-A1 Electrolytic capacitor MITSUBISHI CHEMICAL CORPORATION (JP) 2011-05-18 — — EP disclosed
EP-2323145-A1 Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate MITSUBISHI CHEMICAL CORPORATION (JP) 2011-05-18 — — EP disclosed
US-20090034161-A1 ELECTROLYTIC CAPACITOR MITSUBISHI CHEMICAL CORPORATION (JP) 2009-02-05 — — US disclosed
US-20090034160-A1 ELECTROLYSIS SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR MITSUBISHI CHEMICAL CORPORATION (JP) 2009-02-05 — — US disclosed
US-20070188979-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM MITSUBISHI CHEMICAL CORPORATION (JP) 2007-08-16 — — US disclosed
US-7227738-B2 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2007-06-05 — — US disclosed
US-7072173-B2 Electrolyte for electrolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-07-04 — — US disclosed
US-20060092597-A1 Electrolyte for electrolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-05-04 — — US disclosed
US-20060007629-A1 Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium MITSUBISHI CHEMICAL CORPORATION (JP) 2006-01-12 — — US disclosed
EP-1564768-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM Mitsubishi Chemical Corporation (JP) 2005-08-17 — — EP disclosed
US-20040095708-A1 Electrolyte for electolytic capacitor and electrolytic capacitor using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2004-05-20 — — US disclosed
EP-1394824-A1 ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR USING IT Mitsubishi Chemical Corporation (JP) 2004-03-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326095-A1 ONE-POT WATER-FREE IONIC LIQUIDS SYNTHESIS USING TRIALKYL ORTHOESTERS TNK1, TLK1, WNK1 CHRNA7 2923/4885CYP3A4 2939/4885HSD17B10 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback